KaloBios Comments on Recent Scientific Publication Reporting Significantly Higher Risk of Death Associated With Chagas Infection
25 mai 2017 10h18 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., May 25, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios to Host Company Overview Webinar on May 10
03 mai 2017 08h00 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., May 03, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
Benznidazole on Track in Progress to IND and NDA Submissions
06 avr. 2017 08h00 HE
|
KaloBios Pharmaceuticals Inc.
Investigational new drug (IND) application on track to be submitted in May 2017Manufacturing preparations in line to produce tablets, clinical batches producedCompany anticipates filing new drug...
KaloBios to Participate in Inaugural U.S. Chagas Conference
30 mars 2017 08h00 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., March 30, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios Receives M&A Advisor 2017 Turnaround Award
27 mars 2017 08h00 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios Receives $5.5M in New Financing From Existing Investors
23 mars 2017 16h10 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., March 23, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios to Present at 29th Annual ROTH Conference
09 mars 2017 08h00 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., March 09, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios to Present at Disruptive Growth & Healthcare Conference
13 févr. 2017 08h00 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios Announces Positive Guidance from FDA for Benznidazole
05 janv. 2017 11h20 HE
|
KaloBios Pharmaceuticals Inc.
Minutes received from recent FDA meeting on benznidazole 505(b)(2) regulatory pathway using existing safety and efficacy data is acceptable Benznidazole eligible for neglected tropical...
KaloBios CEO to Participate at FDA/CMS Summit
13 déc. 2016 07h30 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., Dec. 13, 2016 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...